Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Given Imaging introduces PillCam Express, PillCam SB 2-EX
PillCam Express is a video capsule delivery device for patients who are unable to ingest the capsule or who have slow gastric emptying times PillCam SB 2-EX is
PillCam Express is a video capsule delivery device for patients who are unable to ingest the capsule or who have slow gastric emptying times PillCam SB 2-EX is
Astellas Pharma is also expected to transfer the manufacturing and marketing approval for all Intal products to Sanofi-aventis as of 1 October 2010. Intal is a chemical mediator
The Veeva CRM suite of applications includes VBioPharma, VMobile and VInsights. VBioPharma offers multiple editions in one CRM product to accommodate the unique needs of various life sciences
The pre-development agreement provides MorphoSys with an option to enter into a formal co-development for the respective program with Novartis. MorphoSys and Novartis entered into a strategic collaboration
The FAST dressing contains large quantities of the human blood clotting proteins fibrinogen, thrombin and Factor XIII in a dry form, which get instantly activated to form a
The collaboration is focused on translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation. The collaboration will support a number of activities over the
Under the agreement, Pfizer will have exclusive rights to commercialise these products globally, with certain exceptions, including co-exclusive rights for all of the products with Biocon in Germany,
Baraclude is indicated for the treatment of CHB infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or
Qutenza, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the US and the European Union. Qutenza is currently indicated in the
The product is expected to be manufactured under cGMP conditions as a kit for radio-labeling for use in clinical trials. Goodwin operations senior vice president SooYoung Lee said